Melatonin in regulation of inflammatory pathways in rheumatoid arthritis and osteoarthritis: involvement of circadian clock genes

British Journal of Pharmacology

Volumn 175, Issue 16, 2018, Pages 3230-3238

  Jahanban Esfahlan, Rana ^a   Mehrzadi, Saeed ^b   Reiter, Russel J ^c   Seidi, Khaled ^a   Majidinia, Maryam ^d   Baghi, Hossein Bannazadeh ^e   Khatami, Nasrin ^a   Yousefi, Bahman ^f,g   Sadeghpour, Alireza ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ANTIINFLAMMATORY ACTIVITY; ARTHROPATHY; CARTILAGE DEGENERATION; CELL PROTECTION; CIRCADIAN RHYTHM; FREE RADICAL SCAVENGING ASSAY; HORMONE ACTION; HUMAN; INFLAMMATION; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS, RHEUMATOID; CIRCADIAN CLOCKS; HUMANS; MELATONIN; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 85023180055     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13898     Document Type: Review

References (75)

1. Akhtar N, Singh AK, Ahmed S (2016). MicroRNA-17 suppresses TNF-alpha signaling by interfering with TRAF2 and cIAP2 association in rheumatoid arthritis synovial fibroblasts. J Immunol 197: 2219–2228.
2. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
3. Alexander SPH, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol 172: 5956–5978.
4. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
5. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015d). The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors. Br J Pharmacol 172: 5979–6023.
6. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015e). The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 172: 5734–5143.
7. Bang J, Chang HW, Jung HR, Cho CH, Hur JA, Lee SI et al. (2012). Melatonin attenuates clock gene cryptochrome1, which may aggravate mouse anti-type II collagen antibody-induced arthritis. Rheumatol Int 32: 379–385.
8. Berenbaum F, Meng Q-J (2016). The brain-joint axis in osteoarthritis: nerves, circadian clocks and beyond. Nat Rev Rheumatol 12: 508–516.
9. Buttgereit F, Smolen JS, Coogan AN, Cajochen C (2015). Clocking in: chronobiology in rheumatoid arthritis. Nat Rev Rheumatol 11: 349–356.
10. Cano P, Cardinali DP, Chacon F, Reyes Toso CF, Esquifino AI (2002). Nighttime changes in norepinephrine and melatonin content and serotonin turnover in pineal glands of young and old rats injected with Freund's adjuvant. Neuro Endocrinol Lett 23: 49–53.
11. Carlberg C (2000). Gene regulation by melatonin. Ann N Y Acad Sci 917: 387–396.
12. Carrillo-Vico A, Lardone PJ, Alvarez-Sanchez N, Rodriguez-Rodriguez A, Guerrero JM (2013). Melatonin: buffering the immune system. Int J Mol Sci 14: 8638–8683.
13. Chen Q, Wei W (2002). Effects and mechanisms of melatonin on inflammatory and immune responses of adjuvant arthritis rat. Int Immunopharmacol 2: 1443–1449.
14. Chuffa LG, Fioruci-Fontanelli BA, Mendes LO, Ferreira Seiva FR, Martinez M, Favaro WJ et al. (2015). Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer. BMC Cancer 15: 34.
15. Criswell LA (2010). Gene discovery in rheumatoid arthritis highlights the CD40/NF-kappaB signaling pathway in disease pathogenesis. Immunol Rev 233: 55–61.
16. Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S et al. (2005a). Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64: 212–216.
17. Cutolo M, Otsa K, Aakre O, Sulli A (2005b). Nocturnal hormones and clinical rhythms in rheumatoid arthritis. Ann N Y Acad Sci 1051: 372–381.
18. Cutolo M, Villaggio B, Candido F, Valenti S, Giusti M, Felli L et al. (1999). Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann N Y Acad Sci 876: 246–254.
19. Dudek M, Gossan N, Yang N, Im HJ, Ruckshanthi JP, Yoshitane H et al. (2016). The chondrocyte clock gene BMAL1 controls cartilage homeostasis and integrity. J Clin Invest 126: 365–376.
20. Gibbs JE, Ray DW (2013). The role of the circadian clock in rheumatoid arthritis. Arthritis Res Ther 15: 205.
21. Gilmore TD (2006). Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25: 6680–6684.
22. Goldring MB, Otero M (2011). Inflammation in osteoarthritis. Curr Opin Rheumatol 23: 471–478.
23. Gossan N, Boot-Handford R, Meng Q-J (2015). Ageing and osteoarthritis: a circadian rhythm connection. Biogerontology 16: 209–219.
24. Gossan N, Zeef L, Hensman J, Hughes A, Bateman JF, Rowley L et al. (2013). The circadian clock in murine chondrocytes regulates genes controlling key aspects of cartilage homeostasis. Arthritis Rheum 65: 2334–2345.
25. Gregersen PK, Olsson LM (2009). Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 27: 363–391.
26. Guo B, Yang N, Borysiewicz E, Dudek M, Williams JL, Li J et al. (2015). Catabolic cytokines disrupt the circadian clock and the expression of clock-controlled genes in cartilage via an NFкB-dependent pathway. Osteoarthritis Cartilage 23: 1981–1988.
27. Haas S, Straub RH (2012). Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with osteoarthritis and rheumatoid arthritis, role of IL-1beta/TNF. Arthritis Res Ther 14: R122.
28. Hansson I, Holmdahl R, Mattsson R (1990). Constant darkness enhances autoimmunity to type II collagen and exaggerates development of collagen-induced arthritis in DBA/1 mice. J Neuroimmunol 27: 79–84.
29. Hansson I, Holmdahl R, Mattsson R (1992). The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J Neuroimmunol 39: 23–30.
30. Hansson I, Holmdahl R, Mattsson R (1993). Pinealectomy ameliorates collagen II-induced arthritis in mice. Clin Exp Immunol 92: 432–436.
31. Hashiramoto A, Yamane T, Tsumiyama K, Yoshida K, Komai K, Yamada H et al. (2010). Mammalian clock gene Cryptochrome regulates arthritis via proinflammatory cytokine TNF-alpha. J Immunol 184: 1560–1565.
32. Hoesel B, Schmid JA (2013). The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer 12: 1–15.
33. Hoffmann A, Natoli G, Ghosh G (2006). Transcriptional regulation via the NF-kappaB signaling module. Oncogene 25: 6706–6716.
34. Honda KK, Kawamoto T, Ueda HR, Nakashima A, Ueshima T, Yamada RG et al. (2013). Different circadian expression of major matrix-related genes in various types of cartilage: modulation by light-dark conditions. J Biochem 154: 373–381.
35. Hong Y, Hong Y (2015). Anti-arthritic effects of melatonin through blockade of cytonuclear shift of MMP-13. FASEB 29: 4–30.
36. Hosseinzadeh A, Kamrava SK, Joghataei MT, Darabi R, Shakeri-Zadeh A, Shahriari M et al. (2016). Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin. J Pineal Res 61: 411–425.
37. Jahanban-Esfahlan R, de la Guardia M, Ahmadi D, Yousefi B (2017). Modulating tumor hypoxia by nanomedicine for effective cancer therapy. J Cell Physiol https://doi.org/10.1002/jcp.25859. [Epub ahead of print].
38. Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Guerrero JM, Fernandez-Santos JM, Martin-Lacave I et al. (2005). Dual effect of melatonin as proinflammatory and antioxidant in collagen-induced arthritis in rats. J Pineal Res 38: 93–99.
39. Kouri VP, Olkkonen J, Kaivosoja E, Ainola M, Juhila J, Hovatta I et al. (2013). Circadian timekeeping is disturbed in rheumatoid arthritis at molecular level. PLoS One 8: e54049.
40. Li B, Zhang H, Akbar M, Kim HY (2000). Negative regulation of cytosolic phospholipase A(2) by melatonin in the rat pineal gland. Biochem J 351: 709–716.
41. Li Q, Verma IM (2002). NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725–734.
42. Lim HD, Kim YS, Ko SH, Yoon IJ, Cho SG, Chun YH et al. (2012). Cytoprotective and anti-inflammatory effects of melatonin in hydrogen peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model of osteoarthritis via the SIRT1 pathway. J Pineal Res 53: 225–237.
43. Lin HC, Lin TH, Wu MY, Chiu YC, Tang CH, Hour MJ et al. (2014). 5-Lipoxygenase inhibitors attenuate TNF-alpha-induced inflammation in human synovial fibroblasts. PLoS One 9 e107890.
44. Lin YW, Lee LM, Lee WJ, Chu CY, Tan P, Yang YC et al. (2016). Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-kappaB DNA-binding activity. J Pineal Res 60: 277–290.
45. Liu X, Xu Y, Chen S, Tan Z, Xiong K, Li Y et al. (2014). Rescue of proinflammatory cytokine-inhibited chondrogenesis by the antiarthritic effect of melatonin in synovium mesenchymal stem cells via suppression of reactive oxygen species and matrix metalloproteinases. Free Radic Biol Med 68: 234–246.
46. Lu JJ, Fu L, Tang Z, Zhang C, Qin L, Wang J et al. (2016). Melatonin inhibits AP-2beta/hTERT, NF-kappaB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells. Oncotarget 7: 2985–3001.
47. Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M (2002). Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann N Y Acad Sci 966: 271–275.
48. Majidinia M, Sadeghpour A, Mehrzadi S, Reiter RJ, Khatami N, Yousefi B (2017). Melatonin: a pleiotropic molecule that modulates DNA damage response and repair pathways. J Pineal Res https://doi.org/10.1111/jpi.12416. [Epub ahead of print].
49. Mishra A, Paul S, Swarnakar S (2011). Downregulation of matrix metalloproteinase-9 by melatonin during prevention of alcohol-induced liver injury in mice. Biochimie 93: 854–866.
50. Muxel SM, Laranjeira-Silva MF, Carvalho-Sousa CE, Floeter-Winter LM, Markus RP (2016). The RelA/cRel nuclear factor-kappaB (NF-kappaB) dimer, crucial for inflammation resolution, mediates the transcription of the key enzyme in melatonin synthesis in RAW 264.7 macrophages. J Pineal Res 60: 394–404.
51. Nah SS, Won HJ, Park HJ, Ha E, Chung JH, Cho HY et al. (2009). Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21(CIP1)/P27(KIP1) pathways. J Pineal Res 47: 70–74.
52. Narasimamurthy R, Hatori M, Nayak SK, Liu F, Panda S, Verma IM (2012). Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines. Proc Natl Acad Sci U S A 109: 12662–12667.
53. Negi G, Kumar A, Sharma SS (2011). Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-kappaB and Nrf2 cascades. J Pineal Res 50: 124–131.
54. Olkkonen J, Kouri VP, Hynninen J, Konttinen YT, Mandelin J (2015). Differentially expressed in chondrocytes 2 (DEC2) increases the expression of IL-1beta and is abundantly present in synovial membrane in rheumatoid arthritis. PLoS One 10 e0145279.
55. Pap T, Korb-Pap A (2015). Cartilage damage in osteoarthritis and rheumatoid arthritis-two unequal siblings. Nat Rev Rheumatol 11: 606–615.
56. Park JW, Hwang MS, Suh SI, Baek WK (2009). Melatonin down-regulates HIF-1 alpha expression through inhibition of protein translation in prostate cancer cells. J Pineal Res 46: 415–421.
57. Pei M, He F, Wei L, Rawson A (2009). Melatonin enhances cartilage matrix synthesis by porcine articular chondrocytes. J Pineal Res 46: 181–187.
58. Radogna F, Diederich M, Ghibelli L (2010). Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 80: 1844–1852.
59. Reiter RJ, Mayo JC, Tan DX, Sainz RM, Alatorre-Jimenez M, Qin L (2016). Melatonin as an antioxidant: under promises but over delivers. J Pineal Res 61: 253–278.
60. Reiter RJ, Tan DX, Fuentes-Broto L (2010). Melatonin: a multitasking molecule. Prog Brain Res 181: 127–151.
61. Roenneberg T, Merrow M (2005). Circadian clocks – the fall and rise of physiology. Nat Rev Mol Cell Biol 6: 965–971.
62. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res 44: D1054–D1068.
63. Steinhilber D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP et al. (1995). The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 270: 7037–7040.
64. Stratmann M, Stadler F, Tamanini F, van der Horst GT, Ripperger JA (2010). Flexible phase adjustment of circadian albumin D site-binding protein (DBP) gene expression by CRYPTOCHROME1. Genes Dev 24: 1317–1328.
65. Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C et al. (2002). Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966: 276–283.
66. Takahashi JS, Hong HK, Ko CH, McDearmon EL (2008). The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 9: 764–775.
67. Takarada T, Kodama A, Hotta S, Mieda M, Shimba S, Hinoi E et al. (2012). Clock genes influence gene expression in growth plate and endochondral ossification in mice. J Biol Chem 287: 36081–36095.
68. van den Berg WB (2001). Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin Arthritis Rheum 30: 7–16.
69. Wang F, Zhou H, Du Z, Chen X, Zhu F, Wang Z et al. (2015). Cytoprotective effect of melatonin against hypoxia/serum deprivation-induced cell death of bone marrow mesenchymal stem cells in vitro. Eur J Pharmacol 748: 157–165.
70. West SK, Oosthuizen JM (1992). Melatonin levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 3: 33–40.
71. Wiesenberg I, Missbach M, Carlberg C (1998). The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling. Restor Neurol Neurosci 12: 143–150.
72. Yang W, Kang X, Liu J, Li H, Ma Z, Jin X et al. (2016). Clock gene BMAL1 modulates human cartilage gene expression by crosstalk with Sirt1. Endocrinology 157: 3096–3107.
73. Yoshida K, Hashimoto T, Sakai Y, Hashiramoto A (2014a). Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis. J Immunol Res 2014: 1–6.
74. Yoshida K, Hashimoto T, Sakai Y, Hashiramoto A (2014b). Involvement of the circadian rhythm and inflammatory cytokines in the pathogenesis of rheumatoid arthritis. J Immunol Res 2014: 282495.
75. Zhou L, Chen X, Liu T, Gong Y, Chen S, Pan G et al. (2015). Melatonin reverses H2 O2 -induced premature senescence in mesenchymal stem cells via the SIRT1-dependent pathway. J Pineal Res 59: 190–205.